TITLE

Treatment Options For Psoriasis Expanding

AUTHOR(S)
Guttman, Cheryl
PUB. DATE
May 1999
SOURCE
Dermatology Times;May99, Vol. 20 Issue 5, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Identifies emerging therapies for the treatment of psoriasis in the United States. Narrow-band ultraviolet; Mycophenolate mofetil; 6-thioguanine; Corticosteroid foams for scalp use; Biotechnology agents for blocking T-cell activation.
ACCESSION #
1867503

 

Related Articles

  • Topical Psoriasis Therapy. FEDERMAN, DANIEL G.; FROELICH, CATHERINE W.; KIRSNER, ROBERT S. // American Family Physician;2/15/1999, Vol. 59 Issue 4, p957 

    Examines the power and the limitations of topical therapies in the treatment of psoriasis. Pathophysiology; Effectiveness of corticosteroid therapy; Benefits of keratolytic agents.

  • Psoriasis: A short course in topical agents. Greenberg, Robert G. // Cortlandt Forum;May2008, Vol. 21 Issue 5, p23 

    The article presents a treatment option for psoriasis, a chronic skin disease characterized by dry red patches covered with scales. It states that topical corticosteroids are the most common form of treatment for this disease. It advises that the strength, vehicle formulation and quantity...

  • Classical to Current Approach for Treatment of Psoriasis: A Review. Rahman, Mahfoozur; Alam, Kainat; Zaki Ahmad, Mohammad; Gupta, Gaurav; Afzal, Muhammad; Akhter, Sohail; Kazmi, Imran; Jyoti; Jalees Ahmad, Farhan; Anwar, Firoz // Endocrine, Metabolic & Immune Disorders - Drug Targets;Sep2012, Vol. 12 Issue 3, p287 

    Psoriasis is a genetic predisposition with T-cell mediated autoimmune inflammatory skin disorder, characterized by cutaneous inflammation, increased epidermal proliferation, hyperkeratosis, angiogenesis, and abnormal keratinization that affects up to 2 - 3% of the population worldwide. Common...

  • BJD Editor's Choice.  // Journal of Investigative Dermatology;Oct2012, Vol. 132 Issue 10, p2310 

    The article offers information related to the treatment of several skin disorders. It informs that etanercept plus methotrexate can be a viable regimen in the patients suffering from psoriasis. It further states that using oral tofacitinib for treating psoriasis results a significant clinical...

  • Comparative safety of topical calcipotriol (0.005%) versus topical corticosteroid (betamethasone 0.1%) in plaque type psoriasis. Gulam Kazem Ali Ahmad; Choudhury, A. M.; Khondker, Lubna; Khan, M. S. I. // Journal of Pakistan Association of Dermatologists;Oct-Dec2013, Vol. 23 Issue 4, p394 

    Objective To compare the safety of topical calcipotriol (0.005%) and topical corticosteroid (betamethasone 0.1%) in the treatment of plaque type psoriasis. Patients and methods A clinical trial was carried out from January 2012 to August 2012 and patients of plaque type psoriasis attending...

  • Therapeutics.  // Current Medical Literature: Dermatology;2009, Vol. 14 Issue 3, p62 

    The article presents updates on the treatment of skin diseases. An updated guideline for the use of methotrexate in the treatment of psoriasis was released by the Medical Board of National Psoriasis Foundation. Systemic corticosteroids were considered as mainstays for the treatment of chronic...

  • Addition of a Topical Corticosteroid in the Early Phase of Alefacept Treatment for Psoriasis. Bovenschen, H. Jorn; Gerritsen, Wil-Janne; de Jong, Elke M. G. J.; van de Kerkhof, Peter C. M. // Acta Dermato-Venereologica;May2006, Vol. 86 Issue 3, p281 

    The article presents a case study which looks into the effectiveness and efficacy of corticosteroid-alefacept combination treatment for psoriasis in 16 patients. The study has found out a time-related improvement in Psoriasis Area and Severity Index (PASI) despite the failure of the treatment...

  • Fluticasone Topical.  // AHFS Consumer Medication Information;Sep2020, p1 

    Fluticasone, a corticosteroid, is used to reduce inflammation and relieve itching, redness, dryness, and scaling associated with various skin disorders. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review. Patel, Nupur U.; Felix, Kayla; Reimer, Danielle; Feldman, Steven R. // Clinical, Cosmetic & Investigational Dermatology;Sep2017, Vol. 10, p385 

    While topical medications remain the cornerstone of the psoriasis treatment paradigm, they also come with the risk of multiple side effects. An alternative topical treatment option, calcipotriene or calcipotriol, is a vitamin D derivative that is thought to work by inhibiting keratinocyte...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics